nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—ACHE—prostate cancer	0.336	0.783	CbGaD
Rivastigmine—CYP3A4—prostate cancer	0.093	0.217	CbGaD
Rivastigmine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0456	0.154	CbGbCtD
Rivastigmine—CYP2D6—Bicalutamide—prostate cancer	0.0376	0.128	CbGbCtD
Rivastigmine—CYP2D6—Abiraterone—prostate cancer	0.0312	0.106	CbGbCtD
Rivastigmine—CYP3A4—Bicalutamide—prostate cancer	0.0239	0.0811	CbGbCtD
Rivastigmine—CYP3A4—Estramustine—prostate cancer	0.0223	0.0754	CbGbCtD
Rivastigmine—CYP3A4—Abiraterone—prostate cancer	0.0198	0.0672	CbGbCtD
Rivastigmine—CYP3A4—Flutamide—prostate cancer	0.0198	0.0672	CbGbCtD
Rivastigmine—CYP3A4—Cabazitaxel—prostate cancer	0.0147	0.0497	CbGbCtD
Rivastigmine—CYP3A4—Estrone—prostate cancer	0.0143	0.0486	CbGbCtD
Rivastigmine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0128	0.0433	CbGbCtD
Rivastigmine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00938	0.0318	CbGbCtD
Rivastigmine—CYP3A4—Mitoxantrone—prostate cancer	0.00853	0.0289	CbGbCtD
Rivastigmine—CYP3A4—Estradiol—prostate cancer	0.00824	0.0279	CbGbCtD
Rivastigmine—CYP3A4—Prednisone—prostate cancer	0.00708	0.024	CbGbCtD
Rivastigmine—CYP2D6—Doxorubicin—prostate cancer	0.00577	0.0196	CbGbCtD
Rivastigmine—CYP3A4—Etoposide—prostate cancer	0.00538	0.0182	CbGbCtD
Rivastigmine—CYP3A4—Docetaxel—prostate cancer	0.00492	0.0167	CbGbCtD
Rivastigmine—CYP3A4—Doxorubicin—prostate cancer	0.00367	0.0124	CbGbCtD
Rivastigmine—Pyridostigmine—ACHE—prostate cancer	0.00167	0.448	CrCbGaD
Rivastigmine—Neostigmine—ACHE—prostate cancer	0.00127	0.34	CrCbGaD
Rivastigmine—ACHE—prostate gland—prostate cancer	0.000492	0.175	CbGeAlD
Rivastigmine—Pyridostigmine—CYP3A4—prostate cancer	0.000462	0.124	CrCbGaD
Rivastigmine—CYP3A4—urine—prostate cancer	0.000454	0.161	CbGeAlD
Rivastigmine—CYP2D6—urine—prostate cancer	0.000446	0.159	CbGeAlD
Rivastigmine—Tapentadol—CYP2C19—prostate cancer	0.000328	0.0879	CrCbGaD
Rivastigmine—BCHE—prostate gland—prostate cancer	0.000242	0.086	CbGeAlD
Rivastigmine—ACHE—testis—prostate cancer	0.000217	0.0771	CbGeAlD
Rivastigmine—BCHE—seminal vesicle—prostate cancer	0.000205	0.0727	CbGeAlD
Rivastigmine—ACHE—lymph node—prostate cancer	0.000157	0.0559	CbGeAlD
Rivastigmine—BCHE—bone marrow—prostate cancer	0.000125	0.0443	CbGeAlD
Rivastigmine—CYP3A4—renal system—prostate cancer	0.000111	0.0395	CbGeAlD
Rivastigmine—CYP2D6—renal system—prostate cancer	0.000109	0.0388	CbGeAlD
Rivastigmine—BCHE—testis—prostate cancer	0.000107	0.0379	CbGeAlD
Rivastigmine—BCHE—lymph node—prostate cancer	7.72e-05	0.0275	CbGeAlD
Rivastigmine—CYP2D6—testis—prostate cancer	7.06e-05	0.0251	CbGeAlD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.14e-05	0.000105	CcSEcCtD
Rivastigmine—Dyspnoea—Docetaxel—prostate cancer	2.13e-05	0.000105	CcSEcCtD
Rivastigmine—Somnolence—Docetaxel—prostate cancer	2.13e-05	0.000105	CcSEcCtD
Rivastigmine—Discomfort—Prednisone—prostate cancer	2.12e-05	0.000105	CcSEcCtD
Rivastigmine—Eye disorder—Epirubicin—prostate cancer	2.12e-05	0.000105	CcSEcCtD
Rivastigmine—Hypersensitivity—Etoposide—prostate cancer	2.12e-05	0.000105	CcSEcCtD
Rivastigmine—Tinnitus—Epirubicin—prostate cancer	2.12e-05	0.000104	CcSEcCtD
Rivastigmine—Haemoglobin—Doxorubicin—prostate cancer	2.11e-05	0.000104	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.11e-05	0.000104	CcSEcCtD
Rivastigmine—Flushing—Epirubicin—prostate cancer	2.11e-05	0.000104	CcSEcCtD
Rivastigmine—Cardiac disorder—Epirubicin—prostate cancer	2.11e-05	0.000104	CcSEcCtD
Rivastigmine—Rhinitis—Doxorubicin—prostate cancer	2.11e-05	0.000104	CcSEcCtD
Rivastigmine—Dyspepsia—Docetaxel—prostate cancer	2.1e-05	0.000104	CcSEcCtD
Rivastigmine—Haemorrhage—Doxorubicin—prostate cancer	2.1e-05	0.000104	CcSEcCtD
Rivastigmine—Hepatitis—Doxorubicin—prostate cancer	2.1e-05	0.000104	CcSEcCtD
Rivastigmine—Insomnia—Capecitabine—prostate cancer	2.09e-05	0.000103	CcSEcCtD
Rivastigmine—Hypoaesthesia—Doxorubicin—prostate cancer	2.09e-05	0.000103	CcSEcCtD
Rivastigmine—Pharyngitis—Doxorubicin—prostate cancer	2.08e-05	0.000103	CcSEcCtD
Rivastigmine—Paraesthesia—Capecitabine—prostate cancer	2.08e-05	0.000103	CcSEcCtD
Rivastigmine—Decreased appetite—Docetaxel—prostate cancer	2.08e-05	0.000103	CcSEcCtD
Rivastigmine—Urinary tract disorder—Doxorubicin—prostate cancer	2.07e-05	0.000102	CcSEcCtD
Rivastigmine—Oedema peripheral—Doxorubicin—prostate cancer	2.07e-05	0.000102	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Docetaxel—prostate cancer	2.06e-05	0.000102	CcSEcCtD
Rivastigmine—Asthenia—Etoposide—prostate cancer	2.06e-05	0.000102	CcSEcCtD
Rivastigmine—Connective tissue disorder—Doxorubicin—prostate cancer	2.06e-05	0.000102	CcSEcCtD
Rivastigmine—Dyspnoea—Capecitabine—prostate cancer	2.06e-05	0.000102	CcSEcCtD
Rivastigmine—Oedema—Prednisone—prostate cancer	2.06e-05	0.000102	CcSEcCtD
Rivastigmine—Fatigue—Docetaxel—prostate cancer	2.06e-05	0.000102	CcSEcCtD
Rivastigmine—Angiopathy—Epirubicin—prostate cancer	2.06e-05	0.000102	CcSEcCtD
Rivastigmine—Urethral disorder—Doxorubicin—prostate cancer	2.06e-05	0.000102	CcSEcCtD
Rivastigmine—Nausea—Mitoxantrone—prostate cancer	2.05e-05	0.000101	CcSEcCtD
Rivastigmine—Infection—Prednisone—prostate cancer	2.05e-05	0.000101	CcSEcCtD
Rivastigmine—Mediastinal disorder—Epirubicin—prostate cancer	2.05e-05	0.000101	CcSEcCtD
Rivastigmine—Pain—Docetaxel—prostate cancer	2.04e-05	0.000101	CcSEcCtD
Rivastigmine—Constipation—Docetaxel—prostate cancer	2.04e-05	0.000101	CcSEcCtD
Rivastigmine—Dyspepsia—Capecitabine—prostate cancer	2.04e-05	0.000101	CcSEcCtD
Rivastigmine—Chills—Epirubicin—prostate cancer	2.04e-05	0.000101	CcSEcCtD
Rivastigmine—Pruritus—Etoposide—prostate cancer	2.04e-05	0.0001	CcSEcCtD
Rivastigmine—Shock—Prednisone—prostate cancer	2.03e-05	0.0001	CcSEcCtD
Rivastigmine—Arrhythmia—Epirubicin—prostate cancer	2.03e-05	0.0001	CcSEcCtD
Rivastigmine—Visual impairment—Doxorubicin—prostate cancer	2.02e-05	9.99e-05	CcSEcCtD
Rivastigmine—Nervous system disorder—Prednisone—prostate cancer	2.02e-05	9.98e-05	CcSEcCtD
Rivastigmine—Tachycardia—Prednisone—prostate cancer	2.01e-05	9.93e-05	CcSEcCtD
Rivastigmine—Decreased appetite—Capecitabine—prostate cancer	2.01e-05	9.93e-05	CcSEcCtD
Rivastigmine—Alopecia—Epirubicin—prostate cancer	2.01e-05	9.9e-05	CcSEcCtD
Rivastigmine—Skin disorder—Prednisone—prostate cancer	2e-05	9.89e-05	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Capecitabine—prostate cancer	2e-05	9.87e-05	CcSEcCtD
Rivastigmine—Fatigue—Capecitabine—prostate cancer	2e-05	9.85e-05	CcSEcCtD
Rivastigmine—Hyperhidrosis—Prednisone—prostate cancer	1.99e-05	9.84e-05	CcSEcCtD
Rivastigmine—Mental disorder—Epirubicin—prostate cancer	1.99e-05	9.82e-05	CcSEcCtD
Rivastigmine—Erythema multiforme—Doxorubicin—prostate cancer	1.99e-05	9.8e-05	CcSEcCtD
Rivastigmine—Constipation—Capecitabine—prostate cancer	1.98e-05	9.77e-05	CcSEcCtD
Rivastigmine—Pain—Capecitabine—prostate cancer	1.98e-05	9.77e-05	CcSEcCtD
Rivastigmine—Erythema—Epirubicin—prostate cancer	1.98e-05	9.75e-05	CcSEcCtD
Rivastigmine—Malnutrition—Epirubicin—prostate cancer	1.98e-05	9.75e-05	CcSEcCtD
Rivastigmine—Feeling abnormal—Docetaxel—prostate cancer	1.97e-05	9.73e-05	CcSEcCtD
Rivastigmine—Diarrhoea—Etoposide—prostate cancer	1.97e-05	9.72e-05	CcSEcCtD
Rivastigmine—Anorexia—Prednisone—prostate cancer	1.97e-05	9.7e-05	CcSEcCtD
Rivastigmine—Eye disorder—Doxorubicin—prostate cancer	1.96e-05	9.69e-05	CcSEcCtD
Rivastigmine—Tinnitus—Doxorubicin—prostate cancer	1.96e-05	9.67e-05	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Docetaxel—prostate cancer	1.95e-05	9.65e-05	CcSEcCtD
Rivastigmine—Cardiac disorder—Doxorubicin—prostate cancer	1.95e-05	9.62e-05	CcSEcCtD
Rivastigmine—Flushing—Doxorubicin—prostate cancer	1.95e-05	9.62e-05	CcSEcCtD
Rivastigmine—Flatulence—Epirubicin—prostate cancer	1.95e-05	9.61e-05	CcSEcCtD
Rivastigmine—Tension—Epirubicin—prostate cancer	1.94e-05	9.57e-05	CcSEcCtD
Rivastigmine—Dysgeusia—Epirubicin—prostate cancer	1.93e-05	9.55e-05	CcSEcCtD
Rivastigmine—Nervousness—Epirubicin—prostate cancer	1.92e-05	9.47e-05	CcSEcCtD
Rivastigmine—Back pain—Epirubicin—prostate cancer	1.91e-05	9.44e-05	CcSEcCtD
Rivastigmine—Feeling abnormal—Capecitabine—prostate cancer	1.91e-05	9.42e-05	CcSEcCtD
Rivastigmine—Angiopathy—Doxorubicin—prostate cancer	1.91e-05	9.41e-05	CcSEcCtD
Rivastigmine—Dizziness—Etoposide—prostate cancer	1.9e-05	9.39e-05	CcSEcCtD
Rivastigmine—Muscle spasms—Epirubicin—prostate cancer	1.9e-05	9.38e-05	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Capecitabine—prostate cancer	1.89e-05	9.34e-05	CcSEcCtD
Rivastigmine—Mediastinal disorder—Doxorubicin—prostate cancer	1.89e-05	9.34e-05	CcSEcCtD
Rivastigmine—Body temperature increased—Docetaxel—prostate cancer	1.89e-05	9.33e-05	CcSEcCtD
Rivastigmine—Abdominal pain—Docetaxel—prostate cancer	1.89e-05	9.33e-05	CcSEcCtD
Rivastigmine—Chills—Doxorubicin—prostate cancer	1.88e-05	9.3e-05	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Prednisone—prostate cancer	1.88e-05	9.27e-05	CcSEcCtD
Rivastigmine—Arrhythmia—Doxorubicin—prostate cancer	1.88e-05	9.26e-05	CcSEcCtD
Rivastigmine—Insomnia—Prednisone—prostate cancer	1.86e-05	9.21e-05	CcSEcCtD
Rivastigmine—Vision blurred—Epirubicin—prostate cancer	1.86e-05	9.19e-05	CcSEcCtD
Rivastigmine—Alopecia—Doxorubicin—prostate cancer	1.86e-05	9.16e-05	CcSEcCtD
Rivastigmine—Paraesthesia—Prednisone—prostate cancer	1.85e-05	9.14e-05	CcSEcCtD
Rivastigmine—Mental disorder—Doxorubicin—prostate cancer	1.84e-05	9.08e-05	CcSEcCtD
Rivastigmine—Urticaria—Capecitabine—prostate cancer	1.84e-05	9.08e-05	CcSEcCtD
Rivastigmine—Ill-defined disorder—Epirubicin—prostate cancer	1.83e-05	9.05e-05	CcSEcCtD
Rivastigmine—Abdominal pain—Capecitabine—prostate cancer	1.83e-05	9.03e-05	CcSEcCtD
Rivastigmine—Body temperature increased—Capecitabine—prostate cancer	1.83e-05	9.03e-05	CcSEcCtD
Rivastigmine—Vomiting—Etoposide—prostate cancer	1.83e-05	9.03e-05	CcSEcCtD
Rivastigmine—Erythema—Doxorubicin—prostate cancer	1.83e-05	9.03e-05	CcSEcCtD
Rivastigmine—Malnutrition—Doxorubicin—prostate cancer	1.83e-05	9.03e-05	CcSEcCtD
Rivastigmine—Anaemia—Epirubicin—prostate cancer	1.83e-05	9.02e-05	CcSEcCtD
Rivastigmine—Agitation—Epirubicin—prostate cancer	1.82e-05	8.96e-05	CcSEcCtD
Rivastigmine—Dyspepsia—Prednisone—prostate cancer	1.81e-05	8.96e-05	CcSEcCtD
Rivastigmine—Rash—Etoposide—prostate cancer	1.81e-05	8.95e-05	CcSEcCtD
Rivastigmine—Dermatitis—Etoposide—prostate cancer	1.81e-05	8.95e-05	CcSEcCtD
Rivastigmine—Headache—Etoposide—prostate cancer	1.8e-05	8.9e-05	CcSEcCtD
Rivastigmine—Flatulence—Doxorubicin—prostate cancer	1.8e-05	8.89e-05	CcSEcCtD
Rivastigmine—Tension—Doxorubicin—prostate cancer	1.79e-05	8.86e-05	CcSEcCtD
Rivastigmine—Decreased appetite—Prednisone—prostate cancer	1.79e-05	8.85e-05	CcSEcCtD
Rivastigmine—Dysgeusia—Doxorubicin—prostate cancer	1.79e-05	8.84e-05	CcSEcCtD
Rivastigmine—Malaise—Epirubicin—prostate cancer	1.78e-05	8.8e-05	CcSEcCtD
Rivastigmine—Fatigue—Prednisone—prostate cancer	1.78e-05	8.78e-05	CcSEcCtD
Rivastigmine—Nervousness—Doxorubicin—prostate cancer	1.78e-05	8.77e-05	CcSEcCtD
Rivastigmine—Vertigo—Epirubicin—prostate cancer	1.77e-05	8.76e-05	CcSEcCtD
Rivastigmine—Syncope—Epirubicin—prostate cancer	1.77e-05	8.75e-05	CcSEcCtD
Rivastigmine—Back pain—Doxorubicin—prostate cancer	1.77e-05	8.73e-05	CcSEcCtD
Rivastigmine—Constipation—Prednisone—prostate cancer	1.76e-05	8.7e-05	CcSEcCtD
Rivastigmine—Hypersensitivity—Docetaxel—prostate cancer	1.76e-05	8.7e-05	CcSEcCtD
Rivastigmine—Muscle spasms—Doxorubicin—prostate cancer	1.76e-05	8.68e-05	CcSEcCtD
Rivastigmine—Palpitations—Epirubicin—prostate cancer	1.75e-05	8.62e-05	CcSEcCtD
Rivastigmine—Loss of consciousness—Epirubicin—prostate cancer	1.74e-05	8.57e-05	CcSEcCtD
Rivastigmine—Cough—Epirubicin—prostate cancer	1.72e-05	8.51e-05	CcSEcCtD
Rivastigmine—Vision blurred—Doxorubicin—prostate cancer	1.72e-05	8.51e-05	CcSEcCtD
Rivastigmine—Asthenia—Docetaxel—prostate cancer	1.72e-05	8.47e-05	CcSEcCtD
Rivastigmine—Convulsion—Epirubicin—prostate cancer	1.71e-05	8.45e-05	CcSEcCtD
Rivastigmine—Nausea—Etoposide—prostate cancer	1.71e-05	8.44e-05	CcSEcCtD
Rivastigmine—Hypertension—Epirubicin—prostate cancer	1.71e-05	8.42e-05	CcSEcCtD
Rivastigmine—Hypersensitivity—Capecitabine—prostate cancer	1.71e-05	8.42e-05	CcSEcCtD
Rivastigmine—Feeling abnormal—Prednisone—prostate cancer	1.7e-05	8.39e-05	CcSEcCtD
Rivastigmine—Ill-defined disorder—Doxorubicin—prostate cancer	1.7e-05	8.37e-05	CcSEcCtD
Rivastigmine—Pruritus—Docetaxel—prostate cancer	1.69e-05	8.35e-05	CcSEcCtD
Rivastigmine—Anaemia—Doxorubicin—prostate cancer	1.69e-05	8.34e-05	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Prednisone—prostate cancer	1.69e-05	8.32e-05	CcSEcCtD
Rivastigmine—Myalgia—Epirubicin—prostate cancer	1.68e-05	8.3e-05	CcSEcCtD
Rivastigmine—Arthralgia—Epirubicin—prostate cancer	1.68e-05	8.3e-05	CcSEcCtD
Rivastigmine—Chest pain—Epirubicin—prostate cancer	1.68e-05	8.3e-05	CcSEcCtD
Rivastigmine—Agitation—Doxorubicin—prostate cancer	1.68e-05	8.29e-05	CcSEcCtD
Rivastigmine—Anxiety—Epirubicin—prostate cancer	1.68e-05	8.28e-05	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.67e-05	8.25e-05	CcSEcCtD
Rivastigmine—Discomfort—Epirubicin—prostate cancer	1.66e-05	8.21e-05	CcSEcCtD
Rivastigmine—Asthenia—Capecitabine—prostate cancer	1.66e-05	8.2e-05	CcSEcCtD
Rivastigmine—Malaise—Doxorubicin—prostate cancer	1.65e-05	8.14e-05	CcSEcCtD
Rivastigmine—Dry mouth—Epirubicin—prostate cancer	1.64e-05	8.12e-05	CcSEcCtD
Rivastigmine—Vertigo—Doxorubicin—prostate cancer	1.64e-05	8.11e-05	CcSEcCtD
Rivastigmine—Syncope—Doxorubicin—prostate cancer	1.64e-05	8.09e-05	CcSEcCtD
Rivastigmine—Urticaria—Prednisone—prostate cancer	1.64e-05	8.09e-05	CcSEcCtD
Rivastigmine—Pruritus—Capecitabine—prostate cancer	1.64e-05	8.09e-05	CcSEcCtD
Rivastigmine—Diarrhoea—Docetaxel—prostate cancer	1.64e-05	8.08e-05	CcSEcCtD
Rivastigmine—Body temperature increased—Prednisone—prostate cancer	1.63e-05	8.05e-05	CcSEcCtD
Rivastigmine—Abdominal pain—Prednisone—prostate cancer	1.63e-05	8.05e-05	CcSEcCtD
Rivastigmine—Confusional state—Epirubicin—prostate cancer	1.63e-05	8.03e-05	CcSEcCtD
Rivastigmine—Palpitations—Doxorubicin—prostate cancer	1.62e-05	7.98e-05	CcSEcCtD
Rivastigmine—Oedema—Epirubicin—prostate cancer	1.61e-05	7.96e-05	CcSEcCtD
Rivastigmine—Loss of consciousness—Doxorubicin—prostate cancer	1.61e-05	7.93e-05	CcSEcCtD
Rivastigmine—Infection—Epirubicin—prostate cancer	1.6e-05	7.91e-05	CcSEcCtD
Rivastigmine—Cough—Doxorubicin—prostate cancer	1.6e-05	7.88e-05	CcSEcCtD
Rivastigmine—Shock—Epirubicin—prostate cancer	1.59e-05	7.83e-05	CcSEcCtD
Rivastigmine—Convulsion—Doxorubicin—prostate cancer	1.58e-05	7.82e-05	CcSEcCtD
Rivastigmine—Diarrhoea—Capecitabine—prostate cancer	1.58e-05	7.82e-05	CcSEcCtD
Rivastigmine—Nervous system disorder—Epirubicin—prostate cancer	1.58e-05	7.81e-05	CcSEcCtD
Rivastigmine—Dizziness—Docetaxel—prostate cancer	1.58e-05	7.81e-05	CcSEcCtD
Rivastigmine—Thrombocytopenia—Epirubicin—prostate cancer	1.58e-05	7.79e-05	CcSEcCtD
Rivastigmine—Hypertension—Doxorubicin—prostate cancer	1.58e-05	7.79e-05	CcSEcCtD
Rivastigmine—Tachycardia—Epirubicin—prostate cancer	1.57e-05	7.77e-05	CcSEcCtD
Rivastigmine—Skin disorder—Epirubicin—prostate cancer	1.57e-05	7.73e-05	CcSEcCtD
Rivastigmine—Hyperhidrosis—Epirubicin—prostate cancer	1.56e-05	7.7e-05	CcSEcCtD
Rivastigmine—Myalgia—Doxorubicin—prostate cancer	1.56e-05	7.68e-05	CcSEcCtD
Rivastigmine—Chest pain—Doxorubicin—prostate cancer	1.56e-05	7.68e-05	CcSEcCtD
Rivastigmine—Arthralgia—Doxorubicin—prostate cancer	1.56e-05	7.68e-05	CcSEcCtD
Rivastigmine—Anxiety—Doxorubicin—prostate cancer	1.55e-05	7.66e-05	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.55e-05	7.63e-05	CcSEcCtD
Rivastigmine—Discomfort—Doxorubicin—prostate cancer	1.54e-05	7.59e-05	CcSEcCtD
Rivastigmine—Anorexia—Epirubicin—prostate cancer	1.54e-05	7.59e-05	CcSEcCtD
Rivastigmine—Dizziness—Capecitabine—prostate cancer	1.53e-05	7.56e-05	CcSEcCtD
Rivastigmine—Dry mouth—Doxorubicin—prostate cancer	1.52e-05	7.52e-05	CcSEcCtD
Rivastigmine—Vomiting—Docetaxel—prostate cancer	1.52e-05	7.5e-05	CcSEcCtD
Rivastigmine—Hypersensitivity—Prednisone—prostate cancer	1.52e-05	7.5e-05	CcSEcCtD
Rivastigmine—Rash—Docetaxel—prostate cancer	1.51e-05	7.44e-05	CcSEcCtD
Rivastigmine—Hypotension—Epirubicin—prostate cancer	1.51e-05	7.44e-05	CcSEcCtD
Rivastigmine—Dermatitis—Docetaxel—prostate cancer	1.51e-05	7.44e-05	CcSEcCtD
Rivastigmine—Confusional state—Doxorubicin—prostate cancer	1.5e-05	7.43e-05	CcSEcCtD
Rivastigmine—Headache—Docetaxel—prostate cancer	1.5e-05	7.39e-05	CcSEcCtD
Rivastigmine—Oedema—Doxorubicin—prostate cancer	1.49e-05	7.37e-05	CcSEcCtD
Rivastigmine—Infection—Doxorubicin—prostate cancer	1.48e-05	7.32e-05	CcSEcCtD
Rivastigmine—Asthenia—Prednisone—prostate cancer	1.48e-05	7.3e-05	CcSEcCtD
Rivastigmine—Vomiting—Capecitabine—prostate cancer	1.47e-05	7.27e-05	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.47e-05	7.25e-05	CcSEcCtD
Rivastigmine—Shock—Doxorubicin—prostate cancer	1.47e-05	7.25e-05	CcSEcCtD
Rivastigmine—Nervous system disorder—Doxorubicin—prostate cancer	1.46e-05	7.22e-05	CcSEcCtD
Rivastigmine—Thrombocytopenia—Doxorubicin—prostate cancer	1.46e-05	7.21e-05	CcSEcCtD
Rivastigmine—Rash—Capecitabine—prostate cancer	1.46e-05	7.21e-05	CcSEcCtD
Rivastigmine—Pruritus—Prednisone—prostate cancer	1.46e-05	7.2e-05	CcSEcCtD
Rivastigmine—Insomnia—Epirubicin—prostate cancer	1.46e-05	7.2e-05	CcSEcCtD
Rivastigmine—Dermatitis—Capecitabine—prostate cancer	1.46e-05	7.2e-05	CcSEcCtD
Rivastigmine—Tachycardia—Doxorubicin—prostate cancer	1.46e-05	7.19e-05	CcSEcCtD
Rivastigmine—Headache—Capecitabine—prostate cancer	1.45e-05	7.16e-05	CcSEcCtD
Rivastigmine—Skin disorder—Doxorubicin—prostate cancer	1.45e-05	7.16e-05	CcSEcCtD
Rivastigmine—Paraesthesia—Epirubicin—prostate cancer	1.45e-05	7.15e-05	CcSEcCtD
Rivastigmine—Hyperhidrosis—Doxorubicin—prostate cancer	1.44e-05	7.12e-05	CcSEcCtD
Rivastigmine—Dyspnoea—Epirubicin—prostate cancer	1.44e-05	7.1e-05	CcSEcCtD
Rivastigmine—Somnolence—Epirubicin—prostate cancer	1.43e-05	7.08e-05	CcSEcCtD
Rivastigmine—Anorexia—Doxorubicin—prostate cancer	1.42e-05	7.02e-05	CcSEcCtD
Rivastigmine—Nausea—Docetaxel—prostate cancer	1.42e-05	7.01e-05	CcSEcCtD
Rivastigmine—Dyspepsia—Epirubicin—prostate cancer	1.42e-05	7.01e-05	CcSEcCtD
Rivastigmine—Diarrhoea—Prednisone—prostate cancer	1.41e-05	6.96e-05	CcSEcCtD
Rivastigmine—Decreased appetite—Epirubicin—prostate cancer	1.4e-05	6.92e-05	CcSEcCtD
Rivastigmine—Hypotension—Doxorubicin—prostate cancer	1.39e-05	6.88e-05	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Epirubicin—prostate cancer	1.39e-05	6.87e-05	CcSEcCtD
Rivastigmine—Fatigue—Epirubicin—prostate cancer	1.39e-05	6.86e-05	CcSEcCtD
Rivastigmine—Pain—Epirubicin—prostate cancer	1.38e-05	6.81e-05	CcSEcCtD
Rivastigmine—Constipation—Epirubicin—prostate cancer	1.38e-05	6.81e-05	CcSEcCtD
Rivastigmine—Nausea—Capecitabine—prostate cancer	1.37e-05	6.79e-05	CcSEcCtD
Rivastigmine—Dizziness—Prednisone—prostate cancer	1.36e-05	6.73e-05	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.36e-05	6.71e-05	CcSEcCtD
Rivastigmine—Insomnia—Doxorubicin—prostate cancer	1.35e-05	6.66e-05	CcSEcCtD
Rivastigmine—Paraesthesia—Doxorubicin—prostate cancer	1.34e-05	6.61e-05	CcSEcCtD
Rivastigmine—Dyspnoea—Doxorubicin—prostate cancer	1.33e-05	6.57e-05	CcSEcCtD
Rivastigmine—Feeling abnormal—Epirubicin—prostate cancer	1.33e-05	6.56e-05	CcSEcCtD
Rivastigmine—Somnolence—Doxorubicin—prostate cancer	1.33e-05	6.55e-05	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Epirubicin—prostate cancer	1.32e-05	6.51e-05	CcSEcCtD
Rivastigmine—Dyspepsia—Doxorubicin—prostate cancer	1.31e-05	6.48e-05	CcSEcCtD
Rivastigmine—Vomiting—Prednisone—prostate cancer	1.31e-05	6.47e-05	CcSEcCtD
Rivastigmine—Rash—Prednisone—prostate cancer	1.3e-05	6.42e-05	CcSEcCtD
Rivastigmine—Dermatitis—Prednisone—prostate cancer	1.3e-05	6.41e-05	CcSEcCtD
Rivastigmine—Decreased appetite—Doxorubicin—prostate cancer	1.3e-05	6.4e-05	CcSEcCtD
Rivastigmine—Headache—Prednisone—prostate cancer	1.29e-05	6.38e-05	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.29e-05	6.36e-05	CcSEcCtD
Rivastigmine—Fatigue—Doxorubicin—prostate cancer	1.29e-05	6.35e-05	CcSEcCtD
Rivastigmine—Urticaria—Epirubicin—prostate cancer	1.28e-05	6.32e-05	CcSEcCtD
Rivastigmine—Pain—Doxorubicin—prostate cancer	1.28e-05	6.3e-05	CcSEcCtD
Rivastigmine—Constipation—Doxorubicin—prostate cancer	1.28e-05	6.3e-05	CcSEcCtD
Rivastigmine—Abdominal pain—Epirubicin—prostate cancer	1.27e-05	6.29e-05	CcSEcCtD
Rivastigmine—Body temperature increased—Epirubicin—prostate cancer	1.27e-05	6.29e-05	CcSEcCtD
Rivastigmine—Feeling abnormal—Doxorubicin—prostate cancer	1.23e-05	6.07e-05	CcSEcCtD
Rivastigmine—Nausea—Prednisone—prostate cancer	1.22e-05	6.05e-05	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Doxorubicin—prostate cancer	1.22e-05	6.02e-05	CcSEcCtD
Rivastigmine—Hypersensitivity—Epirubicin—prostate cancer	1.19e-05	5.87e-05	CcSEcCtD
Rivastigmine—Urticaria—Doxorubicin—prostate cancer	1.19e-05	5.85e-05	CcSEcCtD
Rivastigmine—Abdominal pain—Doxorubicin—prostate cancer	1.18e-05	5.82e-05	CcSEcCtD
Rivastigmine—Body temperature increased—Doxorubicin—prostate cancer	1.18e-05	5.82e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—TNFRSF21—prostate cancer	1.17e-05	0.000175	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GGT1—prostate cancer	1.17e-05	0.000175	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SLC5A5—prostate cancer	1.17e-05	0.000174	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CBR1—prostate cancer	1.16e-05	0.000173	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ADI1—prostate cancer	1.16e-05	0.000173	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GRHL1—prostate cancer	1.16e-05	0.000173	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—TST—prostate cancer	1.16e-05	0.000173	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CSAD—prostate cancer	1.16e-05	0.000173	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PSAT1—prostate cancer	1.16e-05	0.000173	CbGpPWpGaD
Rivastigmine—Asthenia—Epirubicin—prostate cancer	1.16e-05	5.71e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism—NCOA1—prostate cancer	1.16e-05	0.000172	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP7B1—prostate cancer	1.14e-05	0.00017	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—MTAP—prostate cancer	1.14e-05	0.00017	CbGpPWpGaD
Rivastigmine—Pruritus—Epirubicin—prostate cancer	1.14e-05	5.63e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism—CYP2E1—prostate cancer	1.14e-05	0.00017	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—IGF1—prostate cancer	1.14e-05	0.00017	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP19A1—prostate cancer	1.14e-05	0.00017	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NQO1—prostate cancer	1.13e-05	0.000168	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SULT1E1—prostate cancer	1.11e-05	0.000166	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SRD5A1—prostate cancer	1.11e-05	0.000166	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—TH—prostate cancer	1.11e-05	0.000166	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.1e-05	0.000165	CbGpPWpGaD
Rivastigmine—Diarrhoea—Epirubicin—prostate cancer	1.1e-05	5.45e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism of proteins—MMP2—prostate cancer	1.1e-05	0.000165	CbGpPWpGaD
Rivastigmine—Hypersensitivity—Doxorubicin—prostate cancer	1.1e-05	5.43e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism—CYP3A4—prostate cancer	1.1e-05	0.000164	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—RXRA—prostate cancer	1.1e-05	0.000164	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.09e-05	0.000163	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP1B1—prostate cancer	1.08e-05	0.000161	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.08e-05	0.000161	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CKMT2—prostate cancer	1.08e-05	0.000161	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.08e-05	0.000161	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GRHPR—prostate cancer	1.08e-05	0.000161	CbGpPWpGaD
Rivastigmine—Asthenia—Doxorubicin—prostate cancer	1.07e-05	5.29e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.07e-05	0.000159	CbGpPWpGaD
Rivastigmine—Dizziness—Epirubicin—prostate cancer	1.07e-05	5.26e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—ACSL4—prostate cancer	1.06e-05	0.000158	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HSD17B3—prostate cancer	1.06e-05	0.000158	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—COMT—prostate cancer	1.06e-05	0.000158	CbGpPWpGaD
Rivastigmine—Pruritus—Doxorubicin—prostate cancer	1.06e-05	5.21e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism—GSTP1—prostate cancer	1.05e-05	0.000157	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GGT1—prostate cancer	1.05e-05	0.000156	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ITPR1—prostate cancer	1.04e-05	0.000155	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NCOA1—prostate cancer	1.03e-05	0.000154	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—CXCL8—prostate cancer	1.03e-05	0.000153	CbGpPWpGaD
Rivastigmine—Vomiting—Epirubicin—prostate cancer	1.03e-05	5.06e-05	CcSEcCtD
Rivastigmine—Diarrhoea—Doxorubicin—prostate cancer	1.02e-05	5.04e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.02e-05	0.000152	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ARG2—prostate cancer	1.02e-05	0.000152	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—UMPS—prostate cancer	1.02e-05	0.000152	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PHGDH—prostate cancer	1.02e-05	0.000152	CbGpPWpGaD
Rivastigmine—Rash—Epirubicin—prostate cancer	1.02e-05	5.02e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism—CYP19A1—prostate cancer	1.02e-05	0.000152	CbGpPWpGaD
Rivastigmine—Dermatitis—Epirubicin—prostate cancer	1.02e-05	5.02e-05	CcSEcCtD
Rivastigmine—CYP3A4—Metabolism—NAGLU—prostate cancer	1.01e-05	0.000151	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.01e-05	0.000151	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PGAM2—prostate cancer	1.01e-05	0.000151	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTM3—prostate cancer	1.01e-05	0.000151	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—AOX1—prostate cancer	1.01e-05	0.000151	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—RFK—prostate cancer	1.01e-05	0.000151	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.01e-05	0.000151	CbGpPWpGaD
Rivastigmine—Headache—Epirubicin—prostate cancer	1.01e-05	4.99e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—LDHB—prostate cancer	9.98e-06	0.000149	CbGpPWpGaD
Rivastigmine—Dizziness—Doxorubicin—prostate cancer	9.87e-06	4.87e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism—RXRA—prostate cancer	9.8e-06	0.000146	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—TYMS—prostate cancer	9.8e-06	0.000146	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP3A5—prostate cancer	9.79e-06	0.000146	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTM1—prostate cancer	9.68e-06	0.000144	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP3A43—prostate cancer	9.6e-06	0.000143	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—AMACR—prostate cancer	9.6e-06	0.000143	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SRD5A2—prostate cancer	9.6e-06	0.000143	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—DEGS1—prostate cancer	9.6e-06	0.000143	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NAT1—prostate cancer	9.6e-06	0.000143	CbGpPWpGaD
Rivastigmine—Nausea—Epirubicin—prostate cancer	9.58e-06	4.73e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	9.54e-06	0.000142	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—LPL—prostate cancer	9.5e-06	0.000142	CbGpPWpGaD
Rivastigmine—Vomiting—Doxorubicin—prostate cancer	9.49e-06	4.68e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism of proteins—CTNNB1—prostate cancer	9.48e-06	0.000141	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTA3—prostate cancer	9.46e-06	0.000141	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—UCP3—prostate cancer	9.46e-06	0.000141	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PDHA1—prostate cancer	9.46e-06	0.000141	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—TCN2—prostate cancer	9.46e-06	0.000141	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—COMT—prostate cancer	9.44e-06	0.000141	CbGpPWpGaD
Rivastigmine—Rash—Doxorubicin—prostate cancer	9.41e-06	4.64e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism—GSTP1—prostate cancer	9.4e-06	0.00014	CbGpPWpGaD
Rivastigmine—Dermatitis—Doxorubicin—prostate cancer	9.4e-06	4.64e-05	CcSEcCtD
Rivastigmine—Headache—Doxorubicin—prostate cancer	9.35e-06	4.61e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism—ITPR1—prostate cancer	9.25e-06	0.000138	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP1A1—prostate cancer	9.18e-06	0.000137	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—CXCL8—prostate cancer	9.16e-06	0.000137	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HSD17B1—prostate cancer	9.15e-06	0.000137	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ERCC2—prostate cancer	9.1e-06	0.000136	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	9.09e-06	0.000136	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SLC22A3—prostate cancer	9.02e-06	0.000135	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HSD3B1—prostate cancer	9.02e-06	0.000135	CbGpPWpGaD
Rivastigmine—Nausea—Doxorubicin—prostate cancer	8.86e-06	4.38e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism—TYMS—prostate cancer	8.74e-06	0.00013	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—TBXAS1—prostate cancer	8.65e-06	0.000129	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTA4—prostate cancer	8.65e-06	0.000129	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTM1—prostate cancer	8.64e-06	0.000129	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—MTHFR—prostate cancer	8.56e-06	0.000128	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—LPL—prostate cancer	8.48e-06	0.000126	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—CTNNB1—prostate cancer	8.45e-06	0.000126	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTA2—prostate cancer	8.43e-06	0.000126	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PPARA—prostate cancer	8.4e-06	0.000125	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SULT1A1—prostate cancer	8.33e-06	0.000124	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ABCG5—prostate cancer	8.33e-06	0.000124	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP1A1—prostate cancer	8.19e-06	0.000122	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—B4GALT4—prostate cancer	8.16e-06	0.000122	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HPGD—prostate cancer	8.16e-06	0.000122	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTA1—prostate cancer	8.13e-06	0.000121	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ERCC2—prostate cancer	8.12e-06	0.000121	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTO1—prostate cancer	8.04e-06	0.00012	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HSD3B2—prostate cancer	8.04e-06	0.00012	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NAT2—prostate cancer	8.04e-06	0.00012	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CAV1—prostate cancer	7.89e-06	0.000118	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PLCB2—prostate cancer	7.71e-06	0.000115	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—LRP2—prostate cancer	7.71e-06	0.000115	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP2C18—prostate cancer	7.71e-06	0.000115	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—TNFRSF21—prostate cancer	7.67e-06	0.000114	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—MTHFR—prostate cancer	7.63e-06	0.000114	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—P4HB—prostate cancer	7.56e-06	0.000113	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.54e-06	0.000112	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PPARA—prostate cancer	7.49e-06	0.000112	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—MTAP—prostate cancer	7.46e-06	0.000111	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP7B1—prostate cancer	7.46e-06	0.000111	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SLC22A1—prostate cancer	7.35e-06	0.00011	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SULT1E1—prostate cancer	7.27e-06	0.000108	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SRD5A1—prostate cancer	7.27e-06	0.000108	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CG—prostate cancer	7.19e-06	0.000107	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SULT2A1—prostate cancer	7.17e-06	0.000107	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—MED12—prostate cancer	7.05e-06	0.000105	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CAV1—prostate cancer	7.04e-06	0.000105	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GNG5—prostate cancer	7e-06	0.000104	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ACSL4—prostate cancer	6.94e-06	0.000103	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HSD17B3—prostate cancer	6.94e-06	0.000103	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—INS—prostate cancer	6.81e-06	0.000102	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NCOA3—prostate cancer	6.74e-06	0.000101	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.73e-06	0.0001	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CREBBP—prostate cancer	6.67e-06	9.94e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ARG2—prostate cancer	6.65e-06	9.92e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PHGDH—prostate cancer	6.65e-06	9.92e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—UMPS—prostate cancer	6.65e-06	9.92e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—LDHB—prostate cancer	6.52e-06	9.73e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HPGDS—prostate cancer	6.43e-06	9.59e-05	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CG—prostate cancer	6.41e-06	9.57e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP3A5—prostate cancer	6.4e-06	9.55e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP2C19—prostate cancer	6.39e-06	9.53e-05	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CD—prostate cancer	6.32e-06	9.43e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTT1—prostate cancer	6.24e-06	9.3e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ACHE—prostate cancer	6.24e-06	9.3e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PDHA1—prostate cancer	6.18e-06	9.22e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—TCN2—prostate cancer	6.18e-06	9.22e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—UCP3—prostate cancer	6.18e-06	9.22e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTA3—prostate cancer	6.18e-06	9.22e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP2A6—prostate cancer	6.16e-06	9.19e-05	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—INS—prostate cancer	6.07e-06	9.06e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—AKR1C3—prostate cancer	6e-06	8.94e-05	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—NOS3—prostate cancer	5.97e-06	8.9e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PRKACB—prostate cancer	5.96e-06	8.9e-05	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CREBBP—prostate cancer	5.95e-06	8.87e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP17A1—prostate cancer	5.9e-06	8.81e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HSD3B1—prostate cancer	5.9e-06	8.8e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SLC22A3—prostate cancer	5.9e-06	8.8e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—TBXAS1—prostate cancer	5.66e-06	8.44e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTA4—prostate cancer	5.66e-06	8.44e-05	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CD—prostate cancer	5.64e-06	8.41e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NCOA2—prostate cancer	5.62e-06	8.39e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTA2—prostate cancer	5.51e-06	8.22e-05	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CB—prostate cancer	5.51e-06	8.22e-05	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PTGS2—prostate cancer	5.46e-06	8.14e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ABCG5—prostate cancer	5.44e-06	8.12e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SULT1A1—prostate cancer	5.44e-06	8.12e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SLC5A5—prostate cancer	5.37e-06	8e-05	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NOS3—prostate cancer	5.32e-06	7.94e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTA1—prostate cancer	5.32e-06	7.93e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTO1—prostate cancer	5.26e-06	7.84e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NAT2—prostate cancer	5.26e-06	7.84e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HSD3B2—prostate cancer	5.26e-06	7.84e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP2E1—prostate cancer	5.24e-06	7.82e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NQO1—prostate cancer	5.18e-06	7.73e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—TH—prostate cancer	5.11e-06	7.62e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP3A4—prostate cancer	5.05e-06	7.54e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PLCB2—prostate cancer	5.04e-06	7.52e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—LRP2—prostate cancer	5.04e-06	7.52e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP2C18—prostate cancer	5.04e-06	7.52e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP1B1—prostate cancer	4.97e-06	7.41e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—P4HB—prostate cancer	4.94e-06	7.37e-05	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CB—prostate cancer	4.91e-06	7.33e-05	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PTGS2—prostate cancer	4.87e-06	7.26e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GGT1—prostate cancer	4.81e-06	7.18e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SLC22A1—prostate cancer	4.81e-06	7.17e-05	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PTEN—prostate cancer	4.76e-06	7.1e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NCOA1—prostate cancer	4.74e-06	7.07e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.69e-06	6.99e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP19A1—prostate cancer	4.67e-06	6.97e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—MED12—prostate cancer	4.61e-06	6.88e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GNG5—prostate cancer	4.57e-06	6.82e-05	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—EP300—prostate cancer	4.54e-06	6.77e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—RXRA—prostate cancer	4.51e-06	6.73e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NCOA3—prostate cancer	4.41e-06	6.57e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—COMT—prostate cancer	4.34e-06	6.48e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTP1—prostate cancer	4.32e-06	6.45e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ITPR1—prostate cancer	4.25e-06	6.34e-05	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PTEN—prostate cancer	4.25e-06	6.34e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HPGDS—prostate cancer	4.2e-06	6.27e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.18e-06	6.23e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ACHE—prostate cancer	4.08e-06	6.08e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTT1—prostate cancer	4.08e-06	6.08e-05	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—EP300—prostate cancer	4.05e-06	6.04e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.03e-06	6.01e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—TYMS—prostate cancer	4.02e-06	5.99e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTM1—prostate cancer	3.97e-06	5.92e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.92e-06	5.85e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PRKACB—prostate cancer	3.9e-06	5.82e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—LPL—prostate cancer	3.9e-06	5.82e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.86e-06	5.76e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.76e-06	5.62e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ERCC2—prostate cancer	3.73e-06	5.57e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NCOA2—prostate cancer	3.68e-06	5.49e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—MTHFR—prostate cancer	3.51e-06	5.24e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.51e-06	5.23e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PPARA—prostate cancer	3.44e-06	5.14e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.43e-06	5.11e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NQO1—prostate cancer	3.39e-06	5.05e-05	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CA—prostate cancer	3.36e-06	5.01e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—TH—prostate cancer	3.34e-06	4.98e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.25e-06	4.85e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CAV1—prostate cancer	3.24e-06	4.83e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GGT1—prostate cancer	3.15e-06	4.69e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NCOA1—prostate cancer	3.1e-06	4.62e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.05e-06	4.56e-05	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CA—prostate cancer	3e-06	4.47e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.95e-06	4.4e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—RXRA—prostate cancer	2.95e-06	4.4e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—COMT—prostate cancer	2.84e-06	4.24e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTP1—prostate cancer	2.83e-06	4.22e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—INS—prostate cancer	2.79e-06	4.16e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ITPR1—prostate cancer	2.78e-06	4.15e-05	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—AKT1—prostate cancer	2.74e-06	4.09e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CREBBP—prostate cancer	2.73e-06	4.08e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—TYMS—prostate cancer	2.63e-06	3.92e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTM1—prostate cancer	2.6e-06	3.87e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.59e-06	3.87e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—LPL—prostate cancer	2.55e-06	3.8e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.46e-06	3.67e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NOS3—prostate cancer	2.45e-06	3.65e-05	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—AKT1—prostate cancer	2.45e-06	3.65e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ERCC2—prostate cancer	2.44e-06	3.64e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—MTHFR—prostate cancer	2.29e-06	3.42e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.26e-06	3.37e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PPARA—prostate cancer	2.25e-06	3.36e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PTGS2—prostate cancer	2.24e-06	3.34e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CAV1—prostate cancer	2.12e-06	3.16e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PTEN—prostate cancer	1.95e-06	2.91e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.93e-06	2.88e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—EP300—prostate cancer	1.86e-06	2.78e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—INS—prostate cancer	1.83e-06	2.72e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CREBBP—prostate cancer	1.79e-06	2.67e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.69e-06	2.53e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NOS3—prostate cancer	1.6e-06	2.39e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.48e-06	2.2e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PTGS2—prostate cancer	1.46e-06	2.18e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.38e-06	2.06e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PTEN—prostate cancer	1.28e-06	1.9e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—EP300—prostate cancer	1.22e-06	1.82e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—AKT1—prostate cancer	1.13e-06	1.68e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CA—prostate cancer	9.01e-07	1.34e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—AKT1—prostate cancer	7.36e-07	1.1e-05	CbGpPWpGaD
